The Preeclempsia in Pregnancy, Management and Alternative Approach
DOI:
https://doi.org/10.5281/zenodo.18862665Keywords:
Preeklempsi,, Alternatif, , Yönetim, , Proteinüri.Abstract
Preeclampsia is a disease that begins after the 20th week of pregnancy and is characterized by hypertension and protein in the urine. This condition, which can lead to serious complications during pregnancy, can pose life-threatening risks for the mother and the baby. Although the exact cause of preeclampsia is still unknown, placental abnormalities, immune responses, and genetic factors are thought to play important roles in the development of this disease. Early diagnosis and rapid intervention are critical to prevent maternal and neonatal complications through symptomatic management and birth planning. Diagnostic criteria include a systolic blood pressure of 160 mmHg or a diastolic blood pressure of 110 mmHg on two separate blood pressure measurements taken at least 4 hours apart in a pregnant woman who has no pre-gestational hypertension diagnosis. In addition to elevated blood pressure, platelet count <100,000/ml, renal dysfunction (urine creatinine 1.1 or more or doubling of creatinine level without renal disease), liver enzymes doubling the normal level in liver function tests, epigastric pain unresponsive to medication, severe and persistent right upper quadrant pain, new onset and unresponsive neurological symptoms and visual disturbances, and pulmonary edema accompanying gestational hypertension suggest the diagnosis of preeclampsia. Hypertensive emergencies can be treated with intravenous labetalol, hydralazine, and immediate-release oral nifedipine without the need for invasive cardiac monitoring. There are various methods to prevent the development of preeclampsia. These include aromatherapy, music, vitamin supplements, and calcium supplements.
References
American College of Obstetricians and Gynecologists. (2019). ACOG practice bulletin No. 202: Gestational hypertension and preeclampsia. Obstetrics & Gynecology, 133(1), e1–e25.
American College of Obstetricians and Gynecologists. (2020). Gestational hypertension and preeclampsia: ACOG practice bulletin summary, No. 222. Obstetrics & Gynecology, 135(6), 1492–1495.
Wang, Y., Wu, N., & Shen, H. (2021). Research progress in twin pregnancies complicated by preeclampsia. Risk Management and Healthcare Policy, 14, 1999–2010.
August, P., & Sibai, B. M. (2022). Preeclampsia: Clinical features and diagnosis. UpToDate. Retrieved November 14, 2025, from https://www.uptodate.com
Karrar, S. A., & Hong, P. L. (2023). Preeclampsia. In StatPearls. StatPearls Publishing.
Liu, S., Chan, W. S., Ray, J. G., et al. (2019). Stroke and cerebrovascular disease in pregnancy: Incidence, temporal trends, and risk factors. Stroke, 50(1), 13–20.
Yılmaz, B. (2022). Preeklampsili gebelerde sağlığı geliştirme modeline temellendirilmiş web tabanlı destek programının etkinliği (Doktora tezi). İstanbul Üniversitesi-Cerrahpaşa Lisansüstü Eğitim Enstitüsü.
Rolnik, D. L., Nicolaides, K. H., & Poon, L. C. (2022). Aspirin for the prevention of preeclampsia. American Journal of Obstetrics and Gynecology, 226(2 Suppl.), S1108–S1119.
Doğan Yüksekol, Ö., & Başer, M. (2019). Preeklampside tanı, tedavi ve hemşirelik yaklaşımları. Sağlık Bilimleri Dergisi, 28(2), 94–99.
Wang, W., Xie, X., Yuan, T., Wang, Y., Zhao, F., Zhou, Z., & Zhang, H. (2021). Epidemiological trends of maternal hypertensive disorders of pregnancy at the global, regional, and national levels: A population-based study. BMC Pregnancy and Childbirth, 21(1), Article 364.
Brown, M. A., Magee, L. A., Kenny, L. C., Karumanchi, S. A., McCarthy, F. P., Saito, S., Hall, D. R., Warren, C. E., Adoyi, G., Ishaku, S., & International Society for the Study of Hypertension in Pregnancy. (2018). The hypertensive disorders of pregnancy: ISSHP classification, diagnosis and management recommendations for international practice. Hypertension, 72(1), 24–43.
Ngwenya, S., Jones, B., Mwembe, D., et al. (2021). Determinants of eclampsia among women with severe preeclampsia at Mpilo Central Hospital, Bulawayo, Zimbabwe. Pregnancy Hypertension, 25, 235–239.
Danielli, M., Gillies, C., Thomas, R. C., et al. (2022). The effects of supervised exercise on the development of hypertensive disorders in pregnancy: A systematic review and meta-analysis. Journal of Clinical Medicine, 11(3), Article 793.
Başaran, F. (2025). Türkiye’de hemşirelik alanında preeklampsi konusunda yapılan lisansüstü tezlerin incelenmesi. Munzur Health Science Journal, 1(1), 46–59.
Beech, A., & Mangos, G. (2021). Management of hypertension in pregnancy. Australian Prescriber, 44(5), 148–152.
Irianti, E., Ilyas, S., Hutahaean, S., et al. (2020). Placental histology in preeclamptic rats (Rattus norvegicus) after nanoherbal haramonting (Rhodomyrtus tomentosa) administration. Research Journal of Pharmacy and Technology, 13(8), 3879–3882.
Markovitz, A. R., Stuart, J. J., Horn, J., Williams, P. L., et al. (2019). Does a history of pregnancy complications improve cardiovascular disease risk prediction? Findings from the HUNT Study in Norway. European Heart Journal, 40(14), 1113–1120.
Behram, M., Oğlak, S. C., Bolluk, G., Sezer, S., Özköse, Z. G., Çaypınar, S. S., Acar, Z., & Ölmez, F. (2021). Preeklampsi ile komplike olmuş gebelerde 24 saatlik proteinüri değerlerinin maternal ve perinatal sonuçlar üzerine etkisi. Jinekoloji Obstetrik ve Neonatoloji Tıp Dergisi, 18(1), 717–721.
Thong, E. P., Ghelani, D. P., Manoleehakul, P., et al. (2022). Optimizing cardiometabolic risk factors in pregnancy: A review of risk prediction models targeting gestational diabetes and hypertensive disorders. Journal of Cardiovascular Development and Disease, 9(2), Article 55.
National Institute for Health and Care Excellence. (2019). Hypertension in pregnancy: Diagnosis and management. Retrieved November 14, 2025, from https://www.nice.org.uk
Karahan, H. T., Karahan, E., & Tanoğlu, A. (2022). Gestasyonel hipertansiyon ve güncel tedavi yaklaşımları. Journal of Medical and Palliative Care, 3(2), 122–127.
Öztürk, E., & Hilali, N. G. (2020). Preeklamptik ve eklamptik hastalarda yoğun bakımda kalma süresine etki eden faktörler. Harran Üniversitesi Tıp Fakültesi Dergisi, 17(1), 42–44.
Van Dyk, D., Dyer, R. A., & Fernandes, N. L. (2021). Preeclampsia in 2021—A perioperative medical challenge for the anesthesiologist. Anesthesiology Clinics, 39(4), 711–725.
Cífková, R., Johnson, M. R., Kahan, T., et al. (2020). Peripartum management of hypertension: A position paper of the ESC Council on Hypertension and the European Society of Hypertension. European Heart Journal: Cardiovascular Pharmacotherapy, 6(6), 384–393.
T.C. Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü. (2022). Acil obstetrik bakım yönetim rehberi. T.C. Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü.
Smith, J. M., Lowe, R. F., Fullerton, J., Currie, S. M., Harris, L., & Felker-Kantor, E. (2013). An integrative review of the side effects related to the use of magnesium sulfate for pre-eclampsia and eclampsia management. BMC Pregnancy and Childbirth, 13, Article 34.
Watson, K., Broscious, R., Devabhakthuni, S., & Noel, Z. R. (2018). Focused update on pharmacologic management of hypertensive emergencies. Current Hypertension Reports, 20, Article 56.
European Association for the Study of the Liver. (2023). EASL clinical practice guidelines on the management of liver diseases in pregnancy. Journal of Hepatology, 79(3), 768–828.
McGoldrick, E., Stewart, F., Parker, R., & Dalziel, S. R. (2020). Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database of Systematic Reviews, 12(12), CD004454.
Brown, M. A., Magee, L. A., Kenny, L. C., Karumanchi, S. A., McCarthy, F. P., Saito, S., Hall, D. R., Warren, C. E., Adoyi, G., Ishaku, S., & International Society for the Study of Hypertension in Pregnancy. (2018). The hypertensive disorders of pregnancy: ISSHP classification, diagnosis and management recommendations for international practice. Hypertension, 72(1), 24–43.
Erol, A., Halıcı Öztürk, F., Kırbaş, A., Çelen, Ş., & Çağlar, T. (2020). Nadir bir preeklampsi nedeni: Komplet tip mol hidatiform ve canlı fetusun birlikte bulunduğu ikiz gebelik vaka sunumu ve literatürün gözden geçirilmesi. Jinekoloji Obstetrik ve Neonatoloji Tıp Dergisi, 17(1), 320–322.
Benschop, L., Duvekot, J. J., & Roeters van Lennep, J. E. (2019). Future risk of cardiovascular disease risk factors and events in women after a hypertensive disorder of pregnancy. Heart, 105(16), 1273–1278.
Oğultarhan, Z. (2024). Preeklampsi tanılı gebelerin risk algısı ile anksiyete düzeyi arasındaki ilişkinin incelenmesi (Yüksek lisans tezi). İstanbul Sabahattin Zaim Üniversitesi.
Folk, D. M. (2018). Hypertensive disorders of pregnancy: Overview and current recommendations. Journal of Midwifery & Women’s Health, 63(3), 289–300.
Belay, A. S., & Wudad, T. (2019). Prevalence of preeclampsia and associated factors among pregnant women attending antenatal care at Mettu Karl Referral Hospital, Ethiopia: A cross-sectional study. Clinical Hypertension, 25, Article 14.
Salar, A. R., Kiani, F. Z., & Rezaee, N. (2020). Preventing medication errors in hospitals: A qualitative study. International Journal of Africa Nursing Sciences, 13, 100235.
Durmaz, A., & Elem, E. (2022). Gebelikte hipertansif bozukluklar. In B. Işık, F. Köse, & S. Küçüktürk (Eds.), Sağlık bilimlerinde güncel tartışmalar 1 (ss. 35–56). Duvar Yayınları.
Uzelli Şimşek, H. (2025). Preeklampsi ve eklampside güncel tanı ve tedavi yaklaşımları. In S. Olt (Ed.), Sağlık ve Bilim Güncel Tıp (Vol. 1). Efe Akademi Yayınları.
Eriş Yalçın, S., Nerez, N., & Yalçın, Y. (2025). Gebelikte proteinüri tespitinde spot idrar protein/kreatinin oranı ile 24 saatlik idrar protein atılımının karşılaştırılması. Ahi Evran Medical Journal, 9(3), 379–388.
Oyekale, O. I., Bello, T. O., Ayoola, O., Afolabi, A., Alagbe, O. A., Oyekale, O. T., & Akinyoade, O. N. (2021). The cerebroplacental ratio: Association with maternal hypertension and proteinuria. Radiologia Brasileira, 54(6), 381–387.
Lapalme-Remis, S., & Nguyen, D. K. (2022). Neuroimaging of epilepsy. Continuum, 28(2), 306–338.
Çevik, N. (2025). Preeklampsi ve şiddetli preeklampside gebelerde kandaki selenyum düzeyi ile spot idrarda protein/kreatinin düzeyi arasındaki ilişki (Tıpta uzmanlık tezi). T.C. Sağlık Bilimleri Üniversitesi.
Nonn, O., Debnath, O., Valdes, D. S., Sallinger, K., Secener, A. K., Fischer, C., Tiesmeyer, S., Nimo, J., Kuenzer, T., Ulrich, J., Maxian, T., Knöfler, M., Karau, P., Bartolomaeus, H., Kroneis, T., Frolova, A., Neuper, L., Haase, N., Malt, A., Müller-Bötticher, N., … Herse, F. (2025). Senescent syncytiotrophoblast secretion during early onset preeclampsia. Hypertension, 82(5), 787–799.
Cameron, N. A., Everitt, I. K., Lee, K. A., Yee, L. M., & Khan, S. S. (2023). Chronic hypertension in pregnancy: A lens into cardiovascular disease risk and prevention. Hypertension, 80(6), 1162–1170.
Escudero, C., Kupka, E., Ibañez, B., Sandoval, H., Troncoso, F., Wikström, A.-K., López-Espíndola, D., Acurio, J., Torres-Vergara, P., & Bergman, L. (2023). Brain vascular dysfunction in mothers and their children exposed to preeclampsia. Hypertension, 80(2), 242–256.
Santulli, G., Kansakar, U., & Varzideh, F. (2025). Epidemiology and pathophysiology of preeclampsia: New mechanistic insights. Hypertension, 82(5), 787–799.
Honigberg, M. C., Economy, K. E., Pabon, M. A., Wang, X., Castro, C., Brown, J. M., Divakaran, S., Weber, B. N., Barrett, L., Perillo, A., et al. (2024). Coronary microvascular function following severe preeclampsia. Hypertension, 81, 1272–1284.
Brownfoot, F., & Rolnik, D. L. (2024). Prevention of preeclampsia. Best Practice & Research Clinical Obstetrics & Gynaecology, 93, 102480.
Alp Arıcı, E. C. (2025). Gebelikte preeklampsili vaka sunumu. Wah Academia Journal of Health and Nutrition, 1(2), 1–3.
Burton, G. J., Redman, C. W., Roberts, J. M., & Moffett, A. (2019). Pre-eclampsia: Pathophysiology and clinical implications. BMJ, 366, l2381.
Özdemir, Ö., Mendilcioğlu, İ., Ergün, A., & Madazlı, R. (2025, August 3). Preeklampsi öngörü ve proflaksisi. Maternal-Fetal Tıp ve Perinatoloji Derneği.
Lees, C. C., Stampalija, T., Baschat, A., da Silva Costa, F., Ferrazzi, E., Figueras, F., Hecher, K., Kingdom, J., Poon, L. C., Salomon, L. J., & Unterscheider, J. (2020). ISUOG practice guidelines: Diagnosis and management of small-for-gestational-age fetus and fetal growth restriction. Ultrasound in Obstetrics & Gynecology, 56(2), 298–312.
von Dadelszen, P., Bone, J. N., Sandhu, A., Ansermino, J. M., Qureshi, R. N., Sacoor, C., … Magee, L. A. (2023). Choosing blood pressure thresholds to inform pregnancy care in the community: An analysis of cluster trials. BJOG: An International Journal of Obstetrics & Gynaecology, 130(10), 1275–1285.
Poon, L. C., Magee, L. A., Verlohren, S., Shennan, A., von Dadelszen, P., Sheiner, E., Hadar, E., Visser, G., da Silva Costa, F., Kapur, A., McAuliffe, F., Nazareth, A., Tahlak, M., Kihara, A. B., Divakar, H., McIntyre, H. D., Berghella, V., Yang, H., Romero, R., … Hod, M. (2021). A literature review and best practice advice for second and third trimester risk stratification, monitoring, and management of pre-eclampsia: Compiled by the Pregnancy and Non-Communicable Diseases Committee of FIGO (the International Federation of Gynecology and Obstetrics). International Journal of Gynecology & Obstetrics, 154(Suppl. 1), 3–31.
Ninan, K., Ali, R., Morfaw, F., & McDonald, S. D. (2023). Prevention of pre-eclampsia with aspirin: A systematic review of guidelines and evaluation of the quality of recommendation evidence. International Journal of Gynecology & Obstetrics, 161, 26–39.
Alese, M. O., Moodley, J., & Naicker, T. (2019). Preeclampsia and HELLP syndrome: The role of the liver. The Journal of Maternal-Fetal & Neonatal Medicine, 34(1), 117–123.
Rana, S., Lemoine, E., Granger, J. P., & Karumanchi, S. A. (2019). Preeclampsia: Pathophysiology, challenges, and perspectives. Circulation Research, 124(7), 1094–1112.
Overton, E., Tobes, D., & Lee, A. (2022). Preeclampsia diagnosis and management. Best Practice & Research Clinical Anaesthesiology, 36(1), 107–121.
Eren, D., & Küçükkaya, B. (2023). Preeklamptik gebelerde aromaterapi uygulamaları: Derleme. Balkan Sağlık Bilimleri Dergisi, 2(1), 1–15.
Demir Karakılıç, İ., Uslu Yuvacı, H., & Özden, S. (2018). Gebelikte hipertansif hastalıkların tanısı ve yönetimi. Journal of Human Rhythm, 4(1), 1–8.
Akben, C., & Coşkun, H. (2018). Aromatik kokuların bilişsel ve duygusal etkileri üzerine bir inceleme. Kalem Eğitim ve İnsan Bilimleri Dergisi, 8(1), 215–235.
Puspitasari, Y., Nurhidayah, R., & Katmini, K. (2022). Effectiveness of aromatherapy on lowering blood pressure of preeclampsia mothers during conservative treatment. Jurnal Keperawatan, 14(1), 157–162.
Cardoso, P. M., & Surve, S. (2016). The effect of vitamin E and vitamin C on the prevention of preeclampsia and newborn outcome: A case-control study. The Journal of Obstetrics and Gynecology of India, 66(1), 271–278.
Yang, N., Chen, L., Tang, H., Zeng, Y., & Chen, D. (2020). Effects of music interventions on maternal and child outcomes in obstetric settings: An updated systematic review and meta-analysis. International Journal of Gynecology, Obstetrics and Reproductive Research, 8, 45–59.
Hofmeyr, G. J., Lawrie, T. A., Atallah, Á. N., & Torloni, M. R. (2018). Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database of Systematic Reviews, 10, CD001059.
Fogacci, S., Fogacci, F., & Cicero, A. F. G. (2020). Nutraceuticals and hypertensive disorders in pregnancy: The available clinical evidence. Nutrients, 12(12), 378.
Ford, N. D., Cox, S., Ko, J. Y., Ouyang, L., Romero, L., Colarusso, T., Ferre, C. D., Kroelinger, C. D., Hayes, D. K., & Barfield, W. D. (2022). Hypertensive disorders in pregnancy and mortality at delivery hospitalization—United States, 2017–2019. Morbidity and Mortality Weekly Report, 71(17), 585–591.
Kalkanlı, O. H., & Çalkavur, Ş. (2023). Preeklampsi-eklampsi tanısıyla izlenen anne bebekleri. In E. Z. İnce (Ed.), Annenin hastalıkları ve yenidoğanın sağlığı (pp. 8–16). Türkiye Klinikleri.
Özsoy, S., & Dündar, T. (2021). Gebelikte sıvı dengesi, dengesizlikleri ve hemşirelik yönetimi. In Z. Güneş (Ed.), Sıvı ve elektrolit dengesizliği ve hemşirelik yönetimi (pp. 25–31). Türkiye Klinikleri.
Duman, M., Doğan Yüksekol, Ö., & Durgun Ozan, Y. (2021). Jinekoloji Obstetrik ve Neonatoloji Tıp Dergisi, 18(3), 907–915. [Makale başlığı eksik]
Yuvacı, H. U., Karakılıç, İ. D., & Özden, S. (2018). Hamilelikte hipertansif hastalıklar: Tanı ve yönetim. Journal of Human Rhythm, 4(1), 1–8.
Leeman, L., & Fontaine, P. (2008). Hypertensive disorders of pregnancy. American Family Physician, 78(1), 93–100.
Schroeder, B. M. (2002). ACOG practice bulletin on diagnosis and management of preeclampsia and eclampsia. American Family Physician, 66(2), 330–331.
Hamza, R. Z., Diab, A. A. A., Zahra, M. H., Asalah, A. K., Moursi, S. M. M., Al-Baqami, N. M., Al-Salmi, F. A., & Attia, M. S. (2021). Correlation between apelin and some angiogenic factors in the pathogenesis of preeclampsia: Apelin-13 as a novel drug for treating preeclampsia and its physiological effects on placenta. International Journal of Endocrinology, 2021, Article 5017362.
Thabet, H. A., Dawoud, S. E. S. M., Elnaser, M. G. A., Elnabawey, A., & Goma, L. R. K. (2023). Effect of finger handheld relaxation technique on fatigue and stress among women with preeclampsia. Egyptian Journal of Health Care, 14(2).
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Hatice Kübra İNCE, Fatma YILDIRIM, Nuriye BÜYÜKKAYACI DUMAN
This work is licensed under a Creative Commons Attribution 4.0 International License.
